戻る
「早戻しボタン」を押すと検索画面に戻ります。

今後説明を表示しない

[OK]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 ous cycle of varicella-zoster virus (VZV), a human herpesvirus.
2 nse to infection with this common pathogenic human herpesvirus.
3 The Epstein-Barr virus (EBV) is an oncogenic human herpesvirus.
4 ach of the alpha, beta, and gamma classes of human herpesviruses.
5 gG do not have orthologs in HSV-2 or 8 other human herpesviruses.
6  and gG) do not have orthologs in all 40 non-human herpesviruses.
7 d that have undetectable levels of the eight human herpesviruses.
8 he nucleoside kinase activity of coinfecting human herpesviruses.
9 of novel entry inhibitors of EBV and related human herpesviruses.
10 ause of the species-specific tropism of many human herpesviruses.
11 rticularly murine cytomegalovirus (MCMV) and human herpesviruses.
12 n compared to T-cell responses against other human herpesviruses.
13  to a small genomic region, as seen in other human herpesviruses.
14  the circulating diversity of all classes of human herpesviruses.
15 n varicella-zoster virus (VZV; also known as human herpesvirus 3 [HHV-3]).
16 coma herpesvirus (KSHV), formally designated human herpesvirus 4 (HHV-4) and 8 (HHV-8), respectively,
17              Human cytomegalovirus (HCMV, or human herpesvirus 5 [HHV-5]) is a large DNA-containing v
18 receptor encoded by CMV (also referred to as human herpesvirus 5), a highly prevalent human virus tha
19  inherits a chromosomally integrated copy of human herpesvirus 6 (CI-HHV-6), but the consequences of
20 esence of inherited chromosomally integrated human herpesvirus 6 (ciHHV-6) in hematopoietic cell tran
21                                              Human herpesvirus 6 (HHV-6) and oncogenic Marek's diseas
22            Six immunocompetent patients with human herpesvirus 6 (HHV-6) chromosomal integration had
23                              The majority of human herpesvirus 6 (HHV-6) congenital infections (86%)
24          The prevalence and concentration of human herpesvirus 6 (HHV-6) DNA in the cerebrospinal flu
25        This review evaluates publications on human herpesvirus 6 (HHV-6) encephalitis recognizing fir
26                 Following primary infection, human herpesvirus 6 (HHV-6) establishes a persistent inf
27 mory subsets of CD4(+) and CD8(+) T cells to human herpesvirus 6 (HHV-6) have not been previously inv
28                          Higher incidence of human herpesvirus 6 (HHV-6) infection has been documente
29                                   Congenital human herpesvirus 6 (HHV-6) infection results from germl
30 bella, 309 cases of dengue, and 260 cases of human herpesvirus 6 (HHV-6) infection.
31                                              Human herpesvirus 6 (HHV-6) is detected in the plasma of
32                                              Human herpesvirus 6 (HHV-6) is susceptible to latency an
33                                              Human herpesvirus 6 (HHV-6) species have a unique abilit
34                                              Human herpesvirus 6 (HHV-6) was detected in specimens fr
35 megalovirus (CMV), Epstein-Barr virus (EBV), human herpesvirus 6 (HHV-6), herpes simplex virus types
36 uses such as Marek's disease virus (MDV) and human herpesvirus 6 (HHV-6), integrate their DNA into ho
37 have performed a screen aimed at identifying human herpesvirus 6 (HHV-6)-encoded proteins that modula
38 , cytomegalovirus (CMV), BK virus (BKV), and human herpesvirus 6 (HHV-6).
39                          Here, we describe a human herpesvirus 6 (HHV-6A) chemokine, U83A, which bind
40 (EBV), BK virus (BKV), adenovirus (ADV), and human herpesvirus 6 (HHV6) were evaluated to determine o
41 omes of interest were VR of adenovirus, EBV, human herpesvirus 6 (HHV6), cytomegalovirus (CMV), and B
42                       Coreactivation of both human herpesvirus 6 and cytomegalovirus in ICU patients
43                           The association of human herpesvirus 6 and cytomegalovirus reactivation wit
44 ilation and ICU type, only coreactivation of human herpesvirus 6 and cytomegalovirus was significantl
45        CMV, herpes simplex virus type 1, and human herpesvirus 6 infection were independently associa
46                                              Human herpesvirus 6 is associated with a variety of comp
47                           Most patients with human herpesvirus 6 reactivation also reactivated cytome
48 ical ventilation, burn ICU, major infection, human herpesvirus 6 reactivation, and cytomegalovirus re
49 y and comprehensively assessed the impact of human herpesvirus 6 reactivation, and its interaction wi
50                                              Human herpesvirus 6 viremia occurred in 23% of patients
51 uding BK virus, cytomegalovirus, adenovirus, human herpesvirus 6, and Epstein-Barr virus.
52                                     Viruses (human herpesvirus 6, Epstein-Barr virus, and cytomegalov
53 , enterovirus, herpes simplex virus 1 and 2, human herpesvirus 6, human parechovirus, varicella-zoste
54 9; p = 0.005) compared to patients with only human herpesvirus 6, only cytomegalovirus, or no viral r
55 30 febrile children positive for adenovirus, human herpesvirus 6, or enterovirus infection or with ac
56 galovirus, EBV, adenovirus, BK virus, and/or human herpesvirus 6.
57 inical relevance of chromosomally integrated human herpesvirus-6 (CIHHV-6) after transplantation is n
58            In addition, viral copy number of human herpesvirus-6 (HHV-6) and human herpesvirus-7 (HHV
59                       To investigate whether human herpesvirus-6 (HHV-6) is a causative agent of ence
60                                              Human herpesvirus-6 (HHV-6) is a neurotropic virus that
61                                              Human herpesvirus-6 (HHV-6) is known to reactivate after
62         Previous research has suggested that human herpesvirus-6 (HHV-6) may integrate into host cell
63                     A real-time quantitative human herpesvirus-6 (HHV-6) polymerase chain reaction as
64           Inherited chromosomally integrated human herpesvirus-6 (iciHHV-6) results in the germ-line
65 ations in ATRX and CTNNB1 and integration of human herpesvirus-6 in chromosome 11p.
66 ncluding adenovirus, bocavirus, coronavirus, human herpesvirus-6, lymphocytic choriomeningitis virus,
67  cytomegalovirus (genus Cytomegalovirus) and human herpesvirus 6A (genus Roseolovirus).
68                               The genomes of human herpesvirus 6A (HHV-6A) and HHV-6B have the capaci
69 ous human diseases have been correlated with human herpesvirus 6A (HHV-6A) and HHV-6B, the lack of an
70 ity of the human population is infected with human herpesvirus 6A (HHV-6A), a betaherpesvirus family
71                                              Human herpesvirus 6A (HHV-6A), a member of the betaherpe
72                                              Human herpesvirus 6A (HHV-6A), HHV-6B, and HHV-7 are cla
73                                              Human herpesvirus 6A (HHV-6A), HHV-6B, and HHV-7 are cla
74                     The human roseoloviruses human herpesvirus 6A (HHV-6A), HHV-6B, and HHV-7 compris
75        We show that in T cells infected with human herpesvirus 6A (HHV-6A), the E2F1 protein and its
76                 The U24 protein expressed by human herpesvirus 6A, a ubiquitous human pathogen, has b
77  most closely related to the roseoloviruses, human herpesviruses 6A, 6B, and 7.
78                                              Human herpesviruses 6A/B (HHV-6A/B) can integrate their
79 ier of an inherited-chromosomally-integrated human herpesvirus-6A (iciHHV-6A) genome in one 19q telom
80                          The roseoloviruses, human herpesvirus-6A -6B and -7 (HHV-6A, HHV-6B and HHV-
81                                              Human herpesvirus 6B (HHV-6B) commonly reactivates after
82  is positive for Epstein-Barr virus (EBV) or human herpesvirus 6B (HHV-6B), with one coinfection.
83                                              Human herpesvirus 6B was the species detected in eight s
84 o test for cytomegalovirus, BK polyomavirus, human herpesvirus 6B, HHV-6A, adenovirus, and Epstein-Ba
85  including the closely related human viruses human herpesvirus 7 (HHV-7) and human cytomegalovirus (H
86             In this report, we show that the human herpesvirus 7 (HHV-7) immunoevasin U21, itself a c
87           Here, we identified another virus, human herpesvirus 7 (HHV-7) that interferes with HIV typ
88                           Here, we show that human herpesvirus 7 (HHV-7) U21 binds to and downregulat
89      T cell function, deduced from levels of human herpesvirus 7 and response to hepatitis B immuniza
90                    The U21 gene product from human herpesvirus 7 binds to and redirects class I major
91 of HBV, parvovirus B19, cytomegalovirus, and human herpesvirus 7).
92 py number of human herpesvirus-6 (HHV-6) and human herpesvirus-7 (HHV-7) were measured in both saliva
93              The U21 open reading frame from human herpesvirus-7 encodes a membrane protein that asso
94 ypothesized that they could be infected with human herpesvirus 8 (HHV-8) (Kaposi's sarcoma [KS]-assoc
95                          We have developed a human herpesvirus 8 (HHV-8) 50% tissue culture infective
96 posi's sarcoma-associated herpesvirus (KSHV)/human herpesvirus 8 (HHV-8) and causes KSHV-like disease
97 o investigate a possible association between human herpesvirus 8 (HHV-8) and prostate cancer, we eval
98                                              Human herpesvirus 8 (HHV-8) causes Kaposi sarcoma.
99                                              Human herpesvirus 8 (HHV-8) causes Kaposi's sarcoma and
100 oma (cKS) is an inflammatory tumor caused by human herpesvirus 8 (HHV-8) commonly observed in elderly
101 posi's sarcoma-associated herpesvirus (KSHV)/human herpesvirus 8 (HHV-8) displays two distinct life s
102                                              Human herpesvirus 8 (HHV-8) encodes a viral FLICE inhibi
103                         Here, we report that human herpesvirus 8 (HHV-8) gene product viral interfero
104  children, but there is a paucity of data on human herpesvirus 8 (HHV-8) incidence and routes of infe
105 pulations are associated with the control of human herpesvirus 8 (HHV-8) infection in vivo.
106                                              Human herpesvirus 8 (HHV-8) infection is associated with
107                                              Human herpesvirus 8 (HHV-8) infection is endemic in sub-
108                                              Human herpesvirus 8 (HHV-8) infection occurs in early ch
109                                              Human herpesvirus 8 (HHV-8) interleukin-6 (vIL-6) is dis
110                                              Human herpesvirus 8 (HHV-8) interleukin-6 (vIL-6) promot
111       Viral interleukin-6 (vIL-6) encoded by human herpesvirus 8 (HHV-8) is believed to contribute vi
112                                              Human herpesvirus 8 (HHV-8) is endemic in Uganda and tra
113                                              Human herpesvirus 8 (HHV-8) is the causative agent of Ka
114                                              Human herpesvirus 8 (HHV-8) is the etiological agent of
115                                          The human herpesvirus 8 (HHV-8) viral G protein-coupled rece
116                         The contributions of human herpesvirus 8 (HHV-8) viral interleukin-6 (vIL-6)
117                                              Human herpesvirus 8 (HHV-8) viral interleukin-6 (vIL-6)
118                                              Human herpesvirus 8 (HHV-8) viral interleukin-6 (vIL-6),
119  epithelial cells persistently infected with human herpesvirus 8 (HHV-8), an oncogenic herpesvirus th
120 infected patients, Epstein-Barr virus (EBV), human herpesvirus 8 (HHV-8), cytomegalovirus (CMV), and
121  Other viruses, such as hepatitis B virus or human herpesvirus 8 (HHV-8), establish persistent infect
122 associated herpesvirus (KSHV), also known as human herpesvirus 8 (HHV-8), is a cancer-related human v
123 (RRV), a gammaherpesvirus closely related to human herpesvirus 8 (HHV-8), is described here.
124 0-CD200R pathway during infection, including human herpesvirus 8 (HHV-8), the causative agent of Kapo
125 erent efficiencies and with the exception of human herpesvirus 8 (HHV-8), these chimeric variants res
126                                              Human herpesvirus 8 (HHV-8), which is associated with th
127                                              Human herpesvirus 8 (HHV-8)-encoded viral interleukin-6
128            Kaposi sarcoma is the most common human herpesvirus 8 (HHV-8)-related disease described af
129 most always multicentric (MCD) and linked to human herpesvirus 8 (HHV-8).
130 Ebola virus (EBOV), Tacaribe arenavirus, and human herpesvirus 8 (HHV-8).
131 aque (RM) monkeys that is closely related to human herpesvirus 8 (HHV-8)/Kaposi's Sarcoma-associated
132 iologically linked to the infection with the human herpesvirus 8 (HHV-8/KSHV).
133                                              Human herpesvirus 8 (HHV8) causes multicentric Castleman
134 central Italy and a surveillance program for human herpesvirus 8 (HHV8) infection after transplant, a
135      Kaposi's sarcoma-associated herpesvirus/human herpesvirus 8 (HHV8) ORF50 encodes a transactivato
136                                              Human herpesvirus 8 (HHV8), also known as Kaposi's sarco
137     The lytic origins of DNA replication for human herpesvirus 8 (HHV8), oriLyt-L and oriLyt-R, are l
138 ly improved survival and reduced the risk of human herpesvirus 8 (HHV8)-associated lymphoma.
139 nsfection replication assay identified eight human herpesvirus 8 (HHV8)-encoded proteins required for
140 utively active chemokine receptor encoded by human herpesvirus 8 (HHV8, also known as Kaposi sarcoma
141      Kaposi's sarcoma-associated herpesvirus/human herpesvirus 8 (KSHV/HHV-8) interacts with cell sur
142      Kaposi's sarcoma-associated herpesvirus/human herpesvirus 8 (KSHV/HHV-8) RTA is an important pro
143 irus Kaposi's sarcoma-associated herpesvirus/human herpesvirus 8 (KSHV/HHV8), exploit microtubule (MT
144 osi's sarcoma-associated herpesvirus (KSHV) (human herpesvirus 8 [HHV-8]) induces the host cell's pre
145 -associated herpesvirus (KSHV; also known as human herpesvirus 8 [HHV-8]) is the etiologic agent of K
146 -associated herpesvirus (KSHV; also known as human herpesvirus 8 [HHV-8]), Epstein-Barr virus (EBV),
147 aposi's sarcoma-associated herpesvirus (KSHV/human herpesvirus 8 [HHV8]) and Epstein-Barr virus (EBV/
148 i's sarcoma-associated herpesvirus (KSHV; or human herpesvirus 8 [HHV8]) is implicated in the pathoge
149 ma-associated herpesvirus (KSHV; also called human herpesvirus 8 [HHV8]), the switch from latency to
150                 Expression of the K1 gene of human herpesvirus 8 activates nuclear factor-kappaB and
151 ain at increased KS risk, likely due to high human herpesvirus 8 coinfection rates.
152 requently in saliva and buffy coats than was human herpesvirus 8 DNA.
153 s sarcoma (KS)-associated herpesvirus (KSHV)/human herpesvirus 8 functions as the key regulator to in
154                                              Human herpesvirus 8 interleukin-6 (vIL-6) displays 25% a
155 6 homologue (viral interleukin-6 [vIL-6]) of human herpesvirus 8 is implicated in viral pathogenesis
156                                              Human herpesvirus 8 is the etiologic agent associated wi
157     Viral interleukin-6 (vIL-6) specified by human herpesvirus 8 is, unlike its cellular counterpart,
158                                              Human herpesvirus 8 seroprevalence was 4% (10/249) in do
159 CMV, herpes simplex virus types 1 and 2, and human herpesvirus 8 was 99.4%, 74.9%, 26.2%, 8.0%, and 1
160 osi's sarcoma-associated herpesvirus (KSHV) (human herpesvirus 8) binds to adherent target cell surfa
161 i's sarcoma-associated herpesvirus (KSHV, or human herpesvirus 8) infection in individuals remains a
162 s sarcoma-associated herpesvirus (also named human herpesvirus 8) is a gamma-herpesvirus that undergo
163 persistent gamma-herpesvirus infection (EBV, human herpesvirus 8) is a significant problem in AIDS pa
164 i's sarcoma-associated herpesvirus (KSHV, or human herpesvirus 8) is etiologically linked to KS, and
165 ma-associated herpesvirus (KSHV, also called human herpesvirus 8) is linked to the development of Kap
166 oma-associated herpesvirus (KSHV; also named human herpesvirus 8) is necessary but not sufficient for
167 posi's sarcoma-associated herpesvirus (KSHV, human herpesvirus 8) is the causative agent of Kaposi's
168 s (CMV), herpes simplex virus types 1 and 2, human herpesvirus 8) using multiplex serology on blood s
169 -associated herpesvirus (KSHV, also known as human herpesvirus 8) with the development of the disease
170 aposi's sarcoma-associated herpesvirus (KSHV/human herpesvirus 8).
171 a-associated herpesvirus, also identified as human herpesvirus 8, contains genes producing proteins t
172 associated herpesvirus (KSHV), also known as human herpesvirus 8, is the etiologic agent of Kaposi sa
173 associated herpesvirus (KSHV), also known as human herpesvirus 8, is the etiologic agent underlying K
174 The rhadinovirus 1 (RV1) lineage consists of human herpesvirus 8, Kaposi's sarcoma-associated herpesv
175                Similar to its close relative human herpesvirus 8, rhesus monkey rhadinovirus (RRV) pe
176                                              Human herpesvirus 8, which causes Kaposi sarcoma, expres
177                                              Human herpesvirus 8-DNA was detected in 6.8% and 2.9% of
178                                      Because human herpesvirus 8-encoded K13 selectively activates th
179 Epstein-Barr virus-infected lymphocytes, and human herpesvirus 8-positive primary effusion lymphoma,
180 ted to rhesus macaque rhadinovirus (RRV) and human herpesvirus 8.
181 herpesviruses such as Epstein-Barr virus and human herpesvirus 8.
182  gammaherpesviruses, Epstein-Barr virus, and human herpesvirus 8/Kaposi's sarcoma-associated herpesvi
183 posi's sarcoma-associated herpesvirus (KSHV [human herpesvirus 8; HHV-8]) open reading frame 57 (ORF5
184 onsequence of dysregulated expression of the human herpesvirus-8 (HHV-8 or KSHV)-encoded G protein-co
185 effusion lymphomas (PEL) are associated with human herpesvirus-8 (HHV-8) and usually occur in immunoc
186 ranean Basin, despite the high prevalence of human herpesvirus-8 (HHV-8) infection in this region.
187                                              Human herpesvirus-8 (HHV-8) replication is critical in t
188 s led to a dramatic rise in the incidence of human herpesvirus-8 (HHV-8)-associated Kaposi's sarcoma
189 S), a multifocal vascular neoplasm linked to human herpesvirus-8 (HHV-8/KS-associated herpesvirus [KS
190                          Posttransplantation human herpesvirus-8 (HHV8)/Kaposi sarcoma herpesvirus (K
191 i's sarcoma-associated herpesvirus (KSHV, or human herpesvirus-8 [HHV-8]) has another, alternative em
192 sociation was observed with plasma levels of human herpesvirus-8 DNA.
193 eries regarding Kaposi's sarcoma herpesvirus/human herpesvirus-8 infection and its activation of sign
194 t findings show Kaposi's sarcoma herpesvirus/human herpesvirus-8 specific signaling pathways and pira
195 si's sarcoma-associated herpesvirus (KSHV or human herpesvirus-8) is frequently tumorigenic in immuno
196 osi sarcoma-associated herpesvirus (KSHV; or human herpesvirus-8)-encoded protein called K-bZIP (also
197 mely Kaposi's sarcoma-associated herpesvirus/human herpesvirus-8, has been confirmed to be a direct c
198 nflammatory protein-II (vMIP-II), encoded by human herpesvirus-8, has garnered interest because of it
199 rize major recent findings on the biology of human herpesvirus-8, i.e. Kaposi's sarcoma-associated he
200 on with HIV and Kaposi's sarcoma herpesvirus/human herpesvirus-8, which leads to the development of a
201                 We enrolled HIV-negative and human herpesvirus-8-seronegative patients with symptomat
202 ma is driven by Kaposi's sarcoma herpesvirus/human herpesvirus-8-specific pathways, which include vir
203 liferative disorder caused by infection with human herpesvirus-8.
204 esvirus family including cytomegalovirus and human herpesvirus-8.
205 n shown to be associated with infection with human herpesvirus-8.
206 ction by Kaposi's sarcoma herpesvirus (KSHV)/human herpesvirus-8.
207 re 'pirated' by Kaposi's sarcoma herpesvirus/human herpesvirus-8.
208 ) and HSV-2, two closely related neurotropic human herpesviruses, achieve neurotropism through ICP34.
209     An ORF57 homolog is present in all known human herpesviruses and many animal herpesviruses.
210 the structure of region IX is present in all human herpesviruses and thus represents a potential stru
211             Human cytomegalovirus (CMV) is a human herpesvirus, and infection is widespread in the hu
212                                              Human herpesviruses are among the most prevalent pathoge
213 e against Epstein-Barr virus (EBV) and other human herpesviruses are limited to those targeting viral
214                                              Human herpesviruses are responsible for a range of debil
215           Epstein-Barr virus is a ubiquitous human herpesvirus associated with epithelial and lymphoi
216     Epstein-Barr virus (EBV) is a ubiquitous human herpesvirus associated with many malignant and non
217     Epstein-Barr virus (EBV) is a ubiquitous human herpesvirus associated with the development of bot
218           Because KSBcl-2 and BHRF1 are from human herpesviruses associated with malignancies, we scr
219                                              Human herpesviruses-associated vasculitis can cause vasc
220 de analog, is thought to be specific for the human herpesviruses because it requires a virally encode
221     This study examined the association of 4 human herpesviruses (CMV, herpes simplex virus type 1, h
222 -regulating master circuits in HIV-1 and the human herpesvirus cytomegalovirus along with potential c
223 more differentiated T cells specific for the human herpesviruses cytomegalovirus and Epstein-Barr vir
224          The ORF54-related proteins of other human herpesviruses do not possess this activity, sugges
225 Currently, there are approximately 150 known human herpesvirus-encoded miRNAs, although an miRNA(s) e
226             Our results show VZV, like other human herpesviruses, encodes several sncRNAs and miRNAs,
227 genic latency gene expression program of the human herpesvirus Epstein-Barr virus (EBV).
228 a model our current understanding of how the human herpesvirus Epstein-Barr virus establishes and mai
229                                              Human herpesviruses establish life-long latency in the h
230 sized that HHV-6A, like other members of the human herpesvirus family, encodes miRNAs, which function
231 l mechanism by which HHV-6A, a member of the human herpesvirus family, may contribute to inadequate m
232 g 3 HSV-1 genomes, one HSV-2 genome, 8 other human herpesvirus genomes, and 40 non-human herpesvirus
233  other human herpesvirus genomes, and 40 non-human herpesvirus genomes.
234                                    All eight human herpesviruses have a conserved herpesvirus protein
235                              Since all eight human herpesviruses have UL25 orthologs, this discovery
236                                Although both human herpesvirus (HHV) 6 and HHV-7 infections are ubiqu
237                                              Human herpesvirus (HHV) 6 causes substantial morbidity a
238 nd that certain infectious pathogens such as human herpesvirus (HHV) 6, HHV-7, and adenovirus, which
239 immunological tools available to detect both human herpesvirus (HHV) and immune control of replicatio
240 d men have at least one actively replicating human herpesvirus (HHV) in their mucosal secretions at a
241                                              Human herpesvirus (HHV) infections are common during inf
242  Both human immunodeficiency virus (HIV) and human herpesvirus (HHV) infections persist lifelong, and
243 plant recipients have reactivation of latent human herpesvirus (HHV)-6 2-4 weeks after transplant.
244                              Reactivation of human herpesvirus (HHV)-6 and HHV-7 has been linked to v
245 Both intrauterine and sexual transmission of human herpesvirus (HHV)-6 and HHV-7 have been suggested,
246 tem cell donor with chromosomally integrated human herpesvirus (HHV)-6 and monitored the recipient fo
247 ced hypersensitivity syndrome (DIHS), latent human herpesvirus (HHV)-6 is frequently reactivated in a
248 identification of suitable animal models for human herpesvirus (HHV)-6A and HHV-6B infections has bee
249 for a single virus: Epstein-Barr virus (23), human herpesvirus (HHV)-6B (10), human parainfluenza vir
250       Kaposi sarcoma (KS) is associated with human herpesvirus (HHV)-8 and is dependent on the induct
251 the clinical and virologic manifestations of human herpesvirus (HHV)-8 infection in immunocompetent p
252   Kaposi sarcoma (KS) is primarily caused by human herpesvirus (HHV)-8 infection, and the risk is inc
253 nt studies have found evidence of occasional human herpesvirus (HHV)-8 transmission via blood transfu
254                                              Human herpesviruses (HHV) 6 and 7 are ubiquitous infecti
255                  Infections due to the eight human herpesviruses (HHV) are exacerbated by immunosuppr
256                                              Human herpesviruses (HHV) establish lifelong latent infe
257                  Asymptomatic replication of human herpesviruses (HHV) is frequent in HIV-infected me
258 were as follows: cytomegalovirus (CMV), 44%; human herpesvirus [HHV] 6, 18%; HHV8, 6%; Epstein-Barr v
259 ion is associated with an increased risk for human herpesviruses (HHVs) and their related diseases.
260                             Reactivations of human herpesviruses (HHVs) contribute to the development
261     We investigated the hypothetical role of human herpesviruses (HHVs) in tumour formation of the ce
262               Seminal HIV RNA and DNA from 7 human herpesviruses (HHVs) were measured by real-time po
263 , acts as a DNA chain terminator for several human herpesviruses (HHVs), including HHV-2 (HSV-2), a c
264                    The virion of the largest human herpesvirus, human cytomegalovirus (HCMV), contain
265 lly occurring genetic variants of persistent human herpesviruses imprints on the evolution of the ant
266 us (EBV), known as an oncovirus, is the only human herpesvirus in the genus Lymphocryptovirus (LCV).
267       Nineteen proteins are conserved in all human herpesviruses, including capsid scaffold protein U
268  we found that HDAC inhibiting proteins from human herpesviruses induce human NKG2D ligand ULBP-1.
269 vide additional therapeutic options to treat human herpesvirus infections.
270 t as additional therapeutic options to treat human herpesvirus infections.
271 s sarcoma-associated herpesvirus (KSHV) is a human herpesvirus involved in the causation of several h
272                 The most recently identified human herpesvirus is Kaposi's sarcoma-associated herpesv
273    The epidemiology and essential biology of human herpesvirus is reviewed.
274                                       EBV, a human herpesvirus, is commonly acquired during childhood
275                            EBV, a ubiquitous human herpesvirus, is the causative agent of infectious
276 llular protein and has homologs in all other human herpesviruses, it has potential importance as a th
277  the data suggest that HHV-6 is unique among human herpesviruses: it specifically and efficiently int
278 ecently, 11 miRNAs encoded by the pathogenic human herpesvirus Kaposi's sarcoma-associated herpesviru
279  Kaposi sarcoma (KS) to infection by a novel human herpesvirus (Kaposi sarcoma-associated herpesvirus
280                                              Human herpesviruses may cause severe complications after
281                           All members of the human herpesvirus protease (HHV Pr) family are active as
282 yzed the incidence of infection of the eight human herpesviruses simultaneously in 1 045 peripheral b
283 Human cytomegalovirus (HCMV) is a ubiquitous human herpesvirus that can cause life-threatening diseas
284     Epstein-Barr virus (EBV) is an oncogenic human herpesvirus that dramatically reorganizes host gen
285                Epstein-Barr Virus (EBV) is a human herpesvirus that efficiently establishes latent in
286                          EBV is an oncogenic human herpesvirus that has the ability to infect and tra
287  Epstein-Barr virus is an orally transmitted human herpesvirus that infects epithelial cells and esta
288                          EBV is a ubiquitous human herpesvirus that is associated with various lympho
289     Epstein-Barr virus (EBV) is a ubiquitous human herpesvirus that is causally implicated in the dev
290 , the replication of herpes simplex virus, a human herpesvirus that is closely related to HCMV, was n
291 genomes, combined with the inability of most human herpesviruses to replicate in animals, has until r
292                  Epstein-Barr virus (EBV), a human herpesvirus, transforms B cell growth in vitro thr
293                              Enterovirus and human herpesvirus type 6 had agreements of 95.7% and 85.
294 esviruses (CMV, herpes simplex virus type 1, human herpesvirus type 6, and Epstein-Barr virus) with c
295 afamilial dynamics of endemic infection with human herpesvirus type 8 (HHV-8) in Amerindian populatio
296                           Strikingly, as all human herpesviruses use conserved mRNA processing pathwa
297                          Levels of HIV and 7 human herpesviruses were measured by real-time polymeras
298  we address this issue for EBV, a widespread human herpesvirus with oncogenic potential.
299                  Epstein-Barr virus (EBV), a human herpesvirus with potent B cell growth transforming
300                                  We focus on human herpesviruses, with key insights drawn from veteri

WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。
 
Page Top